Pharmacology for Nurses · Drugs to Treat Myasthenia Gravis and Alzheimer’s Disease
Cholinergic Drugs
On this page 9 sections
In 30 seconds
Cholinergic drugs enhance the action of acetylcholine (ACh), the neurotransmitter of the parasympathetic nervous system and of the neuromuscular junction. They come in two mechanistic families. Direct-acting cholinergic agonists bind cholinergic receptors and mimic ACh themselves. Indirect-acting drugs — the acetylcholinesterase (AChE) inhibitors — block the enzyme that breaks down ACh, so the ACh already released stays in the synapse longer and stimulates receptors longer. Both families strengthen cholinergic signaling, but at different steps.
Because ACh acts on two receptor families — muscarinic (heart, glands, smooth muscle) and nicotinic (neuromuscular junction, ganglia) — cholinergic drugs produce effects across the whole body. That broad reach is therapeutic in some situations (strengthening muscle contraction in myasthenia gravis) and toxic in others (the cholinergic crisis of overstimulation). Understanding where ACh acts explains both the uses and the adverse-effect profile of the class.
Why this matters
Cholinergic drugs are the symptomatic cornerstone of myasthenia gravis treatment and one of the main drug classes for Alzheimer's disease, so they appear throughout this chapter and on exams. Their adverse effects are highly predictable — every Cholinergic drug A medication that enhances acetylcholine signaling Full entry → can produce the "SLUDGE Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis Full entry →" pattern of muscarinic overstimulation — making them excellent teaching examples of how mechanism predicts toxicity. They also carry real safety stakes: an AChE inhibitor A drug that blocks the enzyme breaking down ACh Full entry → overdose causes cholinergic crisis, a life-threatening event a nurse must recognize and distinguish from the disease it treats. And because AChE inhibitors are used beyond neurology (for example, to stimulate the gut and bladder after surgery or reverse certain anticholinergic effects), the class appears across many nursing specialties.
The college version
Core Concepts
The cholinergic system: two receptor families, two jobs
Acetylcholine acts at two receptor families: muscarinic receptors (parasympathetic nerve endings — heart, glands, gut, bladder) and nicotinic receptors (neuromuscular junction and autonomic ganglia). Drugs that boost ACh therefore produce muscarinic effects and nicotinic effects simultaneously — the key to both their therapeutic effects and their adverse effects.
Direct-acting cholinergic agonists
Direct agonists bind cholinergic receptors and reproduce ACh's effects. They are used, for example, to stimulate the bladder (urinary retention) or gut (postoperative ileus) and to lower pressure inside the eye (glaucoma). Pilocarpine is a classic direct muscarinic agonist used in eye care; bethanechol stimulates the bladder and gut. A Direct agonist A drug that binds the receptor and mimics ACh Full entry → is the message — it produces the effect directly by occupying the receptor.
Indirect-acting drugs: acetylcholinesterase inhibitors
The indirect agents do not touch receptors. Instead, they inhibit acetylcholinesterase, the enzyme that rapidly breaks down ACh after release. With the enzyme blocked, each packet of released ACh survives longer. Because the effect depends on naturally released ACh, these drugs work best where ACh is already being released — exactly why they help myasthenia gravis and Alzheimer's disease. Reversible inhibitors are the clinically useful ones (pyridostigmine and neostigmine for MG; donepezil and rivastigmine for Alzheimer's disease). Irreversible inhibitors — organophosphate compounds used as insecticides and nerve agents — are the classic cause of severe cholinergic poisoning.
The predictable adverse-effect pattern: SLUDGE and beyond
Because ACh stimulates glands, smooth muscle, and the heart everywhere, cholinergic excess produces a recognizable cluster of muscarinic effects — remembered with mnemonics such as SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis) plus bradycardia, bronchoconstriction, and miosis. Nicotinic excess at the junction adds muscle twitching and, at high levels, weakness. For a person taking an AChE inhibitor for MG, mild GI symptoms are common; severe SLUDGE signs with bradycardia and bronchospasm signal toxicity. The antidote for dangerous muscarinic effects is an antimuscarinic agent (atropine), which blocks muscarinic receptors — a classic toxicology pairing, always used per protocol and prescriber direction.
Therapeutic uses and nursing implications (mechanism only)
- Myasthenia gravis: AChE inhibitors such as pyridostigmine strengthen skeletal muscle by prolonging ACh at the NMJ. Dosing is individualized and timed around meals and activities so strength peaks when needed. The nurse observes for both inadequate effect (weakness — possible flare) and excessive effect (SLUDGE — possible overdose).
- Alzheimer's disease: CNS-penetrant AChE inhibitors support surviving cholinergic neurons; covered in detail in the Alzheimer's drugs topic.
- Other uses: cholinergic stimulation can help restore gut and bladder function after surgery, and a rapidly acting AChE inhibitor can counter severe anticholinergic poisoning (specialist-directed).
Nursing care for any cholinergic drug starts with a baseline assessment — heart rate, respiratory status, and GI pattern — and includes monitoring for adverse effects, teaching the person what to report, and verifying every dose against current references, the formulary, and the prescriber's orders.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Direct agonist | Indirect (AChE inhibitor) | A direct agonist is the message itself; an indirect drug makes existing messages last longer by blocking ACh breakdown |
| Muscarinic effects | Nicotinic effects | Muscarinic: glands, heart, gut, bladder, eye (SLUDGE, bradycardia, miosis); nicotinic: skeletal muscle (twitching, weakness) |
| Cholinergic crisis | Myasthenic crisis | Cholinergic = too much medication (weakness + SLUDGE + bradycardia); myasthenic = disease flare (weakness, often with a trigger) — opposite treatments |
| Reversible AChE inhibitor | Irreversible AChE inhibitor | Reversible = temporary enzyme block, used therapeutically; irreversible (organophosphates) = permanent block, severe poisoning |
| AChE inhibitor for MG | AChE inhibitor for Alzheimer's | Same mechanism, different target tissue: NMJ (peripheral) vs brain synapses (must cross the BBB) |
| Anticholinergic (blocks ACh) | Cholinergic (boosts ACh) | Opposite classes: anticholinergics dry secretions and speed the heart; cholinergics do the reverse — a classic test trap |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your nerves send messages using a special chemical, and a cleanup crew quickly mops it up so messages don't pile up. Cholinergic drugs come in two types: some pretend to be the chemical itself and deliver the message directly; others stop the cleanup crew so each message lasts longer. That's great when you need stronger messages (like for weak muscles), but if too many pile up, your mouth waters, your stomach cramps, your heart slows, and you get diarrhea — that's the sign of too much drug.
Worked example
A person with myasthenia gravis takes an AChE inhibitor (pyridostigmine) on a schedule timed to their daily routine. The nurse prepares the dose, verifies it against the order and formulary, and checks baseline: heart rate 68, clear lungs, no diarrhea. The person reports that since yesterday their jaw feels weak when chewing and their speech is slightly slurred by evening — possibly the disease breaking through (inadequate cholinergic support) or a trigger such as infection. But when the nurse also notices excessive salivation, abdominal cramping, and a heart rate that has dropped to 52, the picture changes: those are muscarinic overstimulation signs. The nurse holds the dose, notifies the provider, and documents — because in cholinergic excess, giving the scheduled dose would make things worse. The provider evaluates whether the schedule needs adjustment, and the nurse teaches the difference between "weakness that rest helps" (report it) and "watering mouth, cramps, diarrhea, slow pulse" (report immediately — possible too much medication). The core judgment: the same symptom can mean too little drug or too much drug, and muscarinic signs plus timing separate the two.
Key takeaways
- Two families, one goal: direct agonists mimic ACh; AChE inhibitors block its breakdown. Both increase cholinergic signaling.
- Two receptor families: muscarinic (heart, glands, gut, bladder, eye) and nicotinic (skeletal muscle, ganglia) — cholinergic drugs hit both.
- AChE inhibitors work where ACh is already released — why they help myasthenia gravis and Alzheimer's disease.
- SLUDGE = Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis, plus bradycardia, bronchoconstriction, and miosis — the muscarinic toxicity signature.
- Muscle twitching then weakness are the nicotinic excess signs at the junction.
- Cholinergic crisis (drug excess) vs myasthenic crisis (disease flare) — same weakness, opposite treatment directions.
- Atropine (antimuscarinic) blocks muscarinic effects — the classic antidote concept for cholinergic toxicity, per protocol only.
- Baseline and ongoing assessment: heart rate, respiratory status, GI pattern.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
What is the difference between a direct-acting cholinergic agonist and an indirect-acting AChE inhibitor, in mechanism terms?
Show answer
A direct agonist binds cholinergic receptors and mimics acetylcholine, producing the effect itself. An indirect agent blocks the enzyme that breaks down ACh, so naturally released ACh survives longer and stimulates more receptor events. One supplies the message; the other extends the life of the existing message.
List the two cholinergic receptor families and one effect mediated by each.
Show answer
Muscarinic receptors — heart (slower rate), glands (increased secretions), gut and bladder (increased motility), eye (miosis). Nicotinic receptors — skeletal muscle (contraction) and autonomic ganglia (relay signaling).
A person taking an AChE inhibitor develops salivation, diarrhea, cramping, and bradycardia. What is this called, and what is the underlying cause?
Show answer
Cholinergic crisis — excessive cholinergic stimulation from too much medication. The SLUDGE signs plus bradycardia are muscarinic overstimulation; the underlying cause is drug excess, and the immediate response is to hold the dose and notify the provider per protocol.
Why do AChE inhibitors help myasthenia gravis even though they do not replace the destroyed receptors?
Show answer
Because the effect depends on ACh already being released. With the breakdown enzyme blocked, each release lasts longer and has more opportunities to bind the remaining functional receptors, strengthening contraction — even though the antibody-damaged receptors are not repaired.
What is the classic antidote concept for severe muscarinic effects, and why does it work?
Show answer
An antimuscarinic agent such as atropine, which blocks muscarinic receptors. By occupying the receptors that excess ACh would otherwise stimulate, it directly counteracts the dangerous muscarinic effects (bradycardia, secretions, bronchoconstriction). Use is always per protocol and prescriber direction.
How would you distinguish cholinergic crisis from myasthenic crisis at the bedside, and why does the distinction matter?
Show answer
Cholinergic crisis follows the medication dose and pairs weakness with muscarinic signs — salivation, tearing, diarrhea, cramps, bradycardia, miosis. Myasthenic crisis is the disease flaring, often with a trigger, and typically lacks those drug-toxicity signs. The distinction matters because cholinergic crisis requires less cholinergic medication while myasthenic crisis requires more treatment — acting on the wrong diagnosis is dangerous.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Cholinergic drug
- A medication that enhances acetylcholine signaling
- Muscarinic receptor
- ACh receptor on heart, glands, smooth muscle
- Nicotinic receptor
- ACh receptor at the NMJ and ganglia
- Direct agonist
- A drug that binds the receptor and mimics ACh
- AChE inhibitor
- A drug that blocks the enzyme breaking down ACh
- Reversible vs irreversible inhibitor
- Enzyme block that wears off vs. permanent block (organophosphates)
- SLUDGE
- Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.